AzTrials
AzTrials

Cognitive Ability, GeneralNCT02630667

The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition

A study testing SLOW Carbohydrate, MEDIUM Carbohydrate and FAST Carbohydrate in people with Cognitive Ability, General and Dietary Modification, run by University of Illinois at Urbana-Champaign at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the acute effects of ingestion of carbohydrates - with different glycemic profiles - on cognitive function among preadolescent children (i.e., 9-10 years). Read more about this study

Who is it for?
Ages 9 to 10 yearsHealthy volunteers can take part
What is being tested?
SLOW Carbohydrate, MEDIUM Carbohydrate and FAST Carbohydrate
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
113 participants
Where
1 siteUnited States
Study dates
Jun 2012to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Parental/guardian consent.
  • Participants must be between the ages of 9-10 years old at the time of testing age
  • Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task (below 20/20 vision).
  • Participants must have an IQ > 85 (IQ < 85).

Who cannot join

  • Prior diagnosis of cognitive or physical disability, including ADHD (severe asthma, epilepsy, and dependence upon a wheelchair/walking aid, and ADHD Rating Scale score below 85%).
  • Use of anti-psychotic, anti-depressant, anti-anxiety medication, as well as those medications used for ADD/ADHD (use of any anti-psychotic, anti-depressant, anti-anxiety, and ADD/ADHD medications).
  • Early pubertal status, as measured by a modified test of the Tanner Staging System (onset of puberty as determined by Tanner).
  • Lactose intolerance
  • Allergies to milk and/or soy
  • Adherence to a strict vegan diet

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Department of Kinesiology and Community Health

    Urbana, Illinois, 61801

Other trials in United States

About this study

Official title: The Acute Effects of Fortified Nutritional Supplementation on Cognition, Memory, & Achievement

The aim of this study is to investigate the acute effects of ingestion of carbohydrates - with different glycemic profiles - on cognitive function among preadolescent children (i.e., 9-10 years).

Read the detailed description

Regular breakfast consumption is linked to improved cognitive performance in school-aged children. However, the acute benefits of defined nutrient consumption on brain and cognitive health are not well understood, particularly in preadolescent children. One factor that may relate to brain health and learning in children is the contribution of carbohydrates to the digestion rate of a meal (and associated effects on post-prandial glycemia).

The effects of differentially absorbed carbohydrates on brain and cognition are unknown, especially when ingested via a fortified nutritional beverage providing a balanced array of nutrients. The aim of this study is to investigate the acute, transient effect of nutrient supplementation with varied carbohydrate systems in preadolescent children (i.e., 9-10 years).

Participants will be randomized to receive one of three treatment nutritional formulations containing carbohydrates with varying absorption rates along with a non-caloric placebo. Participants will perform a cognitive battery in the fasted condition, shortly after treatment ingestion, and an hour after ingestion. Group differences in performance will be contrasted to assess the effects of different carbohydrate types on children's cognitive function following an overnight fast.

Findings from this study will inform our understanding of the macronutrient profile of breakfast that may potentially improve children's cognitive performance in the morning.

Being tested
SLOW Carbohydrate, MEDIUM Carbohydrate, FAST Carbohydrate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SLOW CarbohydrateOther

    Treatment consists of a carbohydrate blend designed to elicit a slow postprandial glycemic response

  • MEDIUM CarbohydrateOther

    Treatment consists of only one carbohydrate source designed to elicit a medium/moderate postprandial glycemic response

  • FAST CarbohydrateOther

    Treatment consists of only one carbohydrate source designed to elicit a fast postprandial glycemic response

Study groups in NCT02630667
Study groupRoleWhat they receive
SLOW CarbohydrateExperimentalTreatment consists of a carbohydrate blend designed to elicit a slow postprandial glycemic response.
Receives: Other: SLOW Carbohydrate
MEDIUM CarbohydrateExperimentalTreatment consists of only one carbohydrate source designed to elicit a medium/moderate postprandial glycemic response.
Receives: Other: MEDIUM Carbohydrate
FAST CarbohydrateExperimentalTreatment consists of only one carbohydrate source designed to elicit a fast postprandial glycemic response.
Receives: Other: FAST Carbohydrate
Non-Caloric PlaceboPlacebo comparatorNon-caloric placebo consisting of artificial sweeteners
Receives: Other: SLOW Carbohydrate; Other: MEDIUM Carbohydrate; Other: FAST Carbohydrate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Cognitive Control at 15 minutes Postprandial

    Performance will be assessed using the difference in inverse efficiency (during a modified flanker task) between performance at 15 minutes and baseline/fasted (within 2 hours of wake-time) performance.

    Measured: 15 minutes Postprandial

  2. Change in Cognitive Control at 70 minutes Postprandial

    Performance will be assessed using the difference in inverse efficiency (during a modified flanker task) between performance at 70 minutes and baseline/fasted (within 2 hours of wake-time).

    Measured: 70 minutes Postprandial

Secondary outcomes (2)
  1. Change in Relational Memory at 30 minutes Postprandial

    Performance will be assessed using the difference in number of swap errors (during a spatial reconstruction task) by calculating the difference between number of errors performed at baseline/fasted (within 2 hours of wake-time) from number of errors at 30 minutes postprandial.

    Measured: 30 minutes Postprandial

  2. Change in Relational Memory at 85 minutes Postprandial

    Performance will be assessed using the difference in number of swap errors (during a spatial reconstruction task) by calculating the difference between number of errors performed at baseline/fasted (within 2 hours of wake-time) from number of errors at 85 minutes postprandial.

    Measured: 85 minutes Postprandial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2015 (estimated)
  2. Study startJun 2012
  3. Primary completionMay 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
113 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02630667
Sponsor's protocol ID
12641
Status last verified
Dec 2016
First submitted
25 Aug 2015
Last updated
8 Dec 2016
Results posted
No
Data monitoring committee
No

Publications

  • Walk AM, Raine LB, Kramer AF, Cohen NJ, Hillman CH, Khan NA. Adiposity is related to neuroelectric indices of motor response preparation in preadolescent children. Int J Psychophysiol. 2020 Jan;147:176-183. doi: 10.1016/j.ijpsycho.2019.10.014. Epub 2019 Nov 19.

    PubMed 31756405

Questions about this trial

What is this clinical trial studying?

A study testing SLOW Carbohydrate, MEDIUM Carbohydrate and FAST Carbohydrate in people with Cognitive Ability, General and Dietary Modification, run by University of Illinois at Urbana-Champaign at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Cognitive Control at 15 minutes Postprandial (time frame: 15 minutes Postprandial). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02630667, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in